| |
| |
|
| Insider
Information: |
Mendelson Daniel Newman |
| Relationship: |
Director |
| City: |
Washington |
| State: |
DC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
225,806 |
|
|
Indirect Shares
|
100,000 |
|
|
| Direct
Value |
$1,350,283 |
|
|
|
Indirect Value
|
$502,000 |
|
|
| Total
Shares |
325,806 |
|
|
| Total
Value |
$1,852,283 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
26
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
21
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -5.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PharMerica Corporation |
PMC |
Director |
2010-05-26 |
17,629 |
2007-08-07 |
0 |
Premium* |
|
|
HMS Holdings Corp |
HMSY |
Director |
2014-11-12 |
9,552 |
2013-02-27 |
0 |
Premium* |
|
|
Coventry Health Care Inc |
CVH |
Director |
2013-05-07 |
0 |
2013-05-07 |
0 |
Premium* |
|
|
Champions Biotechnology Inc |
CSBR |
Director |
2024-01-12 |
198,625 |
2014-03-20 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2024-01-12 |
4 |
B |
$6.50 |
$6,500 |
D/D |
1,000 |
198,625 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2024-01-11 |
4 |
B |
$6.27 |
$12,540 |
D/D |
2,000 |
197,625 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2024-01-10 |
4 |
B |
$6.31 |
$18,577 |
D/D |
2,944 |
195,625 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2024-01-09 |
4 |
B |
$6.25 |
$18,750 |
D/D |
3,000 |
192,681 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2024-01-08 |
4 |
B |
$6.15 |
$6,150 |
D/D |
1,000 |
189,681 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2024-01-05 |
4 |
B |
$6.09 |
$12,180 |
D/D |
2,000 |
188,681 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2024-01-04 |
4 |
B |
$6.12 |
$18,360 |
D/D |
3,000 |
186,681 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2024-01-03 |
4 |
B |
$5.83 |
$2,915 |
D/D |
500 |
183,681 |
2.31 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-12-21 |
4 |
B |
$4.92 |
$12,300 |
D/D |
2,500 |
183,181 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-12-20 |
4 |
B |
$4.82 |
$10,122 |
D/D |
2,100 |
180,681 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-12-19 |
4 |
B |
$4.75 |
$23,750 |
D/D |
5,000 |
178,581 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-10-11 |
4 |
B |
$6.40 |
$32,000 |
D/D |
5,000 |
163,081 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-10-10 |
4 |
B |
$6.41 |
$7,051 |
D/D |
1,100 |
158,081 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-10-06 |
4 |
B |
$6.48 |
$9,914 |
D/D |
1,530 |
156,981 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-10-05 |
4 |
B |
$6.47 |
$12,940 |
D/D |
2,000 |
155,451 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-10-04 |
4 |
B |
$6.40 |
$32,000 |
D/D |
5,000 |
153,451 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-10-03 |
4 |
B |
$6.30 |
$15,750 |
D/D |
2,500 |
148,451 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-09-29 |
4 |
B |
$6.16 |
$24,640 |
D/D |
4,000 |
173,581 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-09-28 |
4 |
B |
$6.22 |
$31,100 |
D/D |
5,000 |
169,581 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-09-27 |
4 |
B |
$5.95 |
$8,925 |
D/D |
1,500 |
164,581 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-09-26 |
4 |
B |
$5.65 |
$28,250 |
D/D |
5,000 |
145,951 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-09-22 |
4 |
B |
$5.50 |
$20,966 |
D/D |
3,812 |
140,951 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-09-21 |
4 |
B |
$5.51 |
$27,550 |
D/D |
5,000 |
137,139 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-09-20 |
4 |
B |
$5.51 |
$22,139 |
D/D |
4,018 |
132,139 |
2.39 |
% |
|
| CSBR |
Champions Biotechnology I... |
Director |
– • – |
2023-09-19 |
4 |
B |
$5.28 |
$26,400 |
D/D |
5,000 |
128,121 |
2.39 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
